HANSOH PHARMA(03692)

35.340-1.380-3.76%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
HANSOH PHARMA
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
- -
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.
- 08-26
  Interim Report
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2026
  INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2026
- 04-28
  Annual Report
  ANNUAL REPORT 2025
  ANNUAL REPORT 2025

1D
5D
Day
Week
Month

Loading ...

High

36.620

Open

36.060

Volume%

1.03

Low

35.000

Close

36.720

T/O Rate

0.10%

Most Discussed

{"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"03692","data":{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":35.34,"timestamp":1788146137667,"preClose":36.72,"halted":0,"volume":5787535,"delay":0,"changeRate":-0.03758169934640511,"floatShares":6064000000,"shares":6064000000,"eps":1.0844580674495539,"marketStatus":"Trading","change":-1.38,"latestTime":"08-31 11:16:43","open":36.06,"high":36.62,"low":35,"amount":205348163,"amplitude":0.044118,"askPrice":35.36,"askSize":24000,"bidPrice":35.34,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":1.2916513607814237,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788148800000},"marketStatusCode":2,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":36.72,"dividendRate":0.013975,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":1.030809,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"HK879502","market":"hk","labels":[],"media":"HXEx","original_id":"N.HK8RVeNvFKcw","pdf_url":"https://static.tigerbbs.com/f7e68695ff0b4dc9a75360cd488ea05a","pub_time":1787736060000,"showTitleType":false,"size":0,"source":"hk_ex_en_notice","summary":"INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2026","symbol":"03692","title":"INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2026","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600590.pdf","us_notice_code":"Announcements and Notices - [Interim Results / Dividend or Distribution / Closure of Books or Change","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"Interim Report","pubTime":"2026-08-26 17:21","pubTimestamp":1787736060,"notice_type":"","filling_tag":""},{"cdn_pdf":true,"hasAttachments":false,"id":"HK826355","market":"hk","labels":[],"media":"HXEx","original_id":"N.HKGRsfmkhbHu","pdf_url":"https://static.tigerbbs.com/0caf979bb888424cada2b0c60fdb2785","pub_time":1777379400000,"showTitleType":false,"size":0,"source":"hk_ex_en_notice","summary":"ANNUAL REPORT 2025","symbol":"03692","title":"ANNUAL REPORT 2025","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803831.pdf","us_notice_code":"Financial Statements/ESG Information - [Annual Report]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"Annual Report","pubTime":"2026-04-28 20:30","pubTimestamp":1777379400,"notice_type":"","filling_tag":""}],"currentPage":1,"bottom":true},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":0.11},{"period":"1month","weight":0.0955},{"period":"3month","weight":0.1754},{"period":"6month","weight":0.0571},{"period":"1year","weight":0.0415},{"period":"ytd","weight":0.0242}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002557},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.012842},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.033966},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.005203},{"month":6,"riseRate":0.571429,"avgChangeRate":0.039397},{"month":7,"riseRate":0.625,"avgChangeRate":0.011389},{"month":8,"riseRate":0.75,"avgChangeRate":0.034226},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033022},{"month":10,"riseRate":0.142857,"avgChangeRate":0.0016},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063448},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016866}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"aProfile":null}}}